Salimah K, Hardianti MS, Anggorowati N, Taroeno-Hariadi K. Co-expression of BCL2 and C-MYC as a Potential Predictive Factor of Survival in Diffuse Large B Cell Lymphoma with Rituximab-Based Chemotherapy. apjcb [Internet]. 7Jan.2026 [cited 10Jan.2026];11(1):23-9. Available from: http://www.waocp.com/journal/index.php/apjcb/article/view/2097